netFormulary Central Lancashire Formulary NHS
Lancashire Teaching Hospitals NHS Foundation Trust
Chorley and South Ribble CCG
Greater Preston CCG
 
 Search
 Formulary Chapter 13: Skin - Full Chapter
13.05.03  Expand sub section  Drugs affecting the immune response
Adalimumab
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
BlueTeq
 
Link  NICE TA 455: Adalimumab, etanercept and ustekinumab for treating palque psoriasis in children and young people
Link  NICE TA146: Adalimumab for the treatment of adults with psoriasis
Link  NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa
   
Apremilast
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
BlueTeq

Otezla®

 
Link  NICE TA419: Apremilast for treating moderate to severe plaque psoriasis
   
Cytotoxic Drug Azathioprine
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber 2
 
Link  Shared Care Guideline
   
Brodalumab
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq

Kyntheum ®

 
Link  NICE TA 511: Brodalumab for Treating moderate to severe plaque psoriasis
   
Chloroquine
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
   
Ciclosporin
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber 2
 
Link  Shared Care Guideline
   
Colchicine
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Unlicensed Indication

 
   
Dapsone
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
 
   
Dimethyl Fumarate
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq

Skilarence 30mg and 120mg

 
Link  NICE TA 475: Dimethyl fumarate for treating moderate to severe plaque psoriasis
   
Dupilumab
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq
 
Link  NICE TA: Dupilumab for treating moderate to severe atopic dermatitis
   
Etanercept
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq
 
Link  NICE TA103: Psoriasis - efalizumab and etanercept
   
Guselkumab
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq

Tremfya ®

 
Link  NICE TA 521: Guselkumab for treating moderate to severe plaque psoriasis
   
Hydroxycarbamide
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Unlicensed Indication

 
   
Hydroxychloroquine
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
Link  LMMG Prescribing Guidance - Hydroxychloroquine
   
Infliximab
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq
 
Link  NICE TA134: Infliximab for psoriasis
Link  LMMG: Infliximab biosimilars Position Statement
Link  NICE: Biosimilars Position Statement
   
Ixekizumab
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq

Taltz ®

 
Link  NICE TA 442: Ixekizumab for treating moderate to severe plaque psoriasis
   
Leflunomide
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber 2
 
   
Mepacrine
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Unlicensed Medication

 
   
Mesalazine
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
   
Cytotoxic Drug Methotrexate
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber 2
 
Link  Shared Care Guideline
   
Normal Immunoglobulin
(IVIG - Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
 
   
Secukinumab
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
BlueTeq

Cosentyx®

 
Link  NICE TA350: Plaque Psoriasis
   
Thalidomide
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Unlicnesed Indication

 
   
Ustekinumab
(Dermatology)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
BlueTeq
 
Link  NICE TA180: Psoriasis - ustekinumab
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Suitable for prescribing in primary care following recommendation or initiation by a specialist. Little or no specific monitoring required. Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care. Brief prescribing document or information sheet may be required.  

Amber 1

Suitable for prescribing in primary care following recommendation or initiation by a specialist. Minimal monitoring required. Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care. Full prior agreement about patientís on-going care must be reached under the shared care agreement.  

Amber 2

Initiated by specialist and transferred to primary care following a successful initiation period. Significant monitoring required on an on-going basis. Full prior agreement about patientís on-going care must be reached under the shared care agreement. Suitable for enhanced service.  

Black

NOT recommended for use by the NHS in Lancashire. Includes medicines that NICE has not recommended for use and terminated technology appraisals, unless there is a local need.  

Blue

Products shown as blue have different Traffic Light List classifications dependent on indication. See the accompanying text next to the product for further information  

Green

Appropriate for initiation and ongoing prescribing in both primary and secondary care. Generally, little or no routine drug monitoring is required.  

Purple

Low Priority for Prescribing - see Low Priority for Prescribing Policy  

Red

Medicine is supplied by the hospital for the duration of the treatment course. Primary care initiation or continuation of treatment is not recommended unless exceptional circumstances such as specialist GP.  

Red Specialist Centre

Prescribing restricted to Specialist Centres only  

netFormulary